The companies are developing a rapid, at-home colorectal cancer test that uses interstitial fluid as a sample type.

The firm's Genomics revenues increased 89 percent, while Data and Services revenues rose 43 percent year over year.

The firm reported growth across its immunodiagnostics and molecular diagnostics businesses as well as contributions from the firm's licensed technologies business.

Labcorp will acquire multiple same-day testing labs and select technical assets from Incyte, including its main anatomic pathology lab in Spokane, Washington.

Last week, readers were most interested in a story about Mursla's liver cancer test for detecting microRNA and protein targets within extracellular vesicles.

The firm said that it slashed its GAAP EPS guidance and made a smaller cut to its non-GAAP EPS guidance in response to US tariffs and other geopolitical conditions.

The proceeds will be used to launch a new diagnostic instrument, a breast cancer monitoring assay, and proprietary multiplex immunofluorescence reagent kits.

The firm said that it slashed its GAAP EPS guidance and made a smaller cut to its non-GAAP EPS guidance in response to US tariffs and other geopolitical conditions.

The firm raised a total of $13.5 million in its Series A equity financing round, which will go toward growing and advancing its neurodegenerative disease testing business.

NEW YORK – Uppsala University spinout Readily Diagnostics is using technology built off 30 years of research as the basis of a point-of-care, instrument-free test that would detect and differentiate ...

The former True Health Diagnostics executives were accused of participating in a scheme that paid Texas physicians for blood test referrals.